◀ Back to IL5
IL5 — MBP
Text-mined interactions from Literome
Chen et al., Mult Scler 2001
(Multiple Sclerosis) :
Some GA-specific TCL, ( approximately 25 % ) generated during treatment secreted predominantly
IL-5 in
response to
MBP and the immunodominant MBP peptide 83-99, indicating that these crossreactive antigens can act as partial agonists for GA-reactive TCL
Murata et al., Eur J Neurol 2003
(Eosinophilia...) :
These results suggest that
IL-5 induces local accumulation of eosinophils and their release of
MBP
Lopez et al., J Interferon Cytokine Res 2003
:
IFN-gamma ( 100 U/ml ) and TNF-alpha ( 1000 U/ml ) or
IL-5 ( 200 pM )
caused a significant increase in the expression of the eosinophil peroxidase (EPO) and the
major basic protein (MBP) genes
Hedegaard et al., Immunology 2008
(Multiple Sclerosis, Relapsing-Remitting) :
A strong correlation was found between the
MBP induced CD4+ T-cell proliferation and production of IL-17, IFN-gamma,
IL-5 and IL-4 ( P < 0.0001 to P < 0.01 ) within the patient group, and the production of IL-17 and IL-5 correlated with the number of active plaques on magnetic resonance images ( P=0.04 and P=0.007 )
Hedegaard et al., Clin Immunol 2008
(Multiple Sclerosis) :
No significant change was observed in the
MBP induced CD4+ T cell proliferation, or in the production of IL-4,
IL-5 and brain derived neurotrophic factor
Selmaj et al., Clin Exp Immunol 1988
(Multiple Sclerosis) :
Multiple sclerosis :
effect of
myelin basic protein on
interleukin 1, interleukin 2 production and interleukin 2 receptor expression in vitro